Jiuzhou Pharma/九洲药业

🥂 🎉 "Cheers to the new year and new beginnings! 🌟🚀Jiuzhou Pharma/九洲药业 team wishes you a prosperous year filled with success and happiness. 💖🌈 Here's to 2025 being even more amazing! Happy New Year!" 🎆🎊 #Jiuzhoupharma #2025 #CDMO #Tides

We are excited to announce that Kai Rossen has joined Jiuzhou Pharma/九洲药业 as the Director of the Scientific and Technological Strategy Committee and Head of European Business for #InnovativeDrugs. With over 37 years of experience in drug design and process development, Kai Rossen brings invaluable expertise to our team. Recently, Kai Rossen concluded a successful 10-year tenure as Editor-in-Chief of Organic Process Research & Development (OPR&D), where he significantly contributed to the journal's evolution and its role in bridging academia and industry. His farewell letter expresses gratitude for the journey and highlights the importance of collaboration in advancing scientific research. https://lnkd.in/g47YFj8B At Jiuzhou Pharma/九洲药业, Kai Rossen is focused on enhancing our strategic research initiatives and driving innovation in drug development. His leadership will strengthen our commitment to providing high-quality, efficient R&D and manufacturing solutions. Jiuzhou Pharma/九洲药业 is dedicated to being a global leader in #CDMO services for innovative drugs, leveraging our advanced technology platforms and extensive global network. We look forward to achieving new milestones under Kai Rossen's guidance. Stay tuned for more updates as we continue our mission to deliver better treatment options for patients worldwide!

🎄🎅 Merry Christmas from the Jiuzhou Pharma/九洲药业 Japan CRO Team! 🌟🔬 Our Japan CRO is dedicated to providing cutting-edge solutions in the field of chemical process development, offering CMC support for your drug development. 🧪 🎉🥂 Once again, wishing you a Merry Christmas and a Happy New Year filled with joy and prosperity! 🌈💫 #Jiuzhoupharm #CDMO #CRO #CMC Naokazu Nonaka

🎄 Merry Christmas from Jiuzhou Pharma Europe! 🎄 As we celebrate the festive season, we at Jiuzhou Pharma Europe are thrilled to wish you all a Merry Christmas and a prosperous New Year ahead! 🎉 💪 The team at Jiuzhou Pharma Europe will be composed primarily of PhD organic chemists with diverse backgrounds and excellent training, enabling them to draw from a wide range of knowledge and experience. The leadership team, deeply involved in strategic and tactical decisions, will leverage decades of process development experience to deliver the best possible outcomes for custom Jiuzhou Pharma/九洲药业 #CDMO #CRO

The Jiuzhou Pharma/九洲药业 / Raybow USA US Small Molecule Business Development team wishes everyone a Merry Christmas! At Jiuzhou Pharma/Raybow, we are proud to be a trusted partner in CDMO services for small molecules and peptides, offering: ✅ Custom API development and manufacturing ✅ Seamless transition from clinical to commercial scale ✅ Expertise in solid-phase and solution-phase peptide synthesis ✅ Proven track record of regulatory excellence Whether you’re looking to accelerate timelines, ensure reliable supply, or tackle complex chemistry challenges, we are here to help turn your scientific breakthroughs into success stories. Thank you to all our customers and partners for your trust and collaboration this year! We’re excited to continue building strong partnerships and driving innovation in 2025. Robert Geiger Tim Miley Mark Vermeulen, MBA Matthew Lauer #JiuzhouPharma #CDMO #APIManufacturing #Peptides #SmallMolecules #Partnerships #BrevardNC #PharmaInnovation #Frommoleculetomarket

🎄 Jiuzhou Pharma wishes you all a very Merry Christmas! We are deeply indebted to our global customers, partners, and colleagues, and we would like to take this opportunity to express our sincere gratitude. 🎅 💕 What binds us tightly across continents is our unwavering commitment to our noble mission: Serve Life, Guard Health. This is not only manifested through our advanced #CDMO services but also in our continuous efforts to innovate and development. This Christmas, we celebrate not only the season's joy but also the valuable partnerships and friendships that have made our work not only efficient but also meaningful. 🤗 🎅All the employees of Jiuzhou Pharma extend our warmest and most sincere wishes to you and your families. May your holidays be filled with laughter, love, and delightful memories. As we look ahead to the coming year, we anticipate a journey filled with remarkable breakthroughs and sustained success. Here's to a happy holiday season and a prosperous New Year! 🎇 #HappyHolidays #MerryChristmas #Jiuzhoupharma #CDMO #API #Tides

Kicking Off the Holiday Season in Beautiful Brevard, NC! The Jiuzhou Pharma/九洲药业 / Raybow US Small Molecule Business Development team had the pleasure of hosting some of our valued customers at our Brevard, NC site before the holiday break. Nestled in the serene beauty of the Blue Ridge Mountains, the waterfall behind us perfectly symbolizes the energy and momentum we’re bringing into 2025! At Jiuzhou Pharma/Raybow, we are proud to be a trusted partner in CDMO services for small molecules and peptides, offering: ✅ Custom API development and manufacturing ✅ Seamless transition from clinical to commercial scale ✅ Expertise in solid-phase and solution-phase peptide synthesis ✅ Proven track record of regulatory excellence Whether you’re looking to accelerate timelines, ensure reliable supply, or tackle complex chemistry challenges, we are here to help turn your scientific breakthroughs into success stories. Thank you to all our customers and partners for your trust and collaboration this year! We’re excited to continue building strong partnerships and driving innovation in 2025. Tim Miley Mark Vermeulen, MBA Matthew Lauer #JiuzhouPharma #CDMO #APIManufacturing #Peptides #SmallMolecules #Partnerships #BrevardNC #PharmaInnovation #Frommoleculetomarket

Join Jiuzhou Pharma/九洲药业 and Raybow at #DCAT Week 2025 in New York! It’s the most pivotal event for the pharmaceutical industry-- where innovation meets opportunity. Let’s talk about how Jiuzhou Pharma and Raybow USA can help take your projects “From Molecule to Market.”   With 16+ years of global CDMO and manufacturing expertise at Jiuzhou Pharma, and Raybow USA’s specialized focus on Peptides, Small Molecules, and Oligonucleotides, we are your trusted partner for transforming ideas into production-ready solutions.   Together, we can shape the future of pharmaceutical innovation!   Why Partner with us? Global Scope: international manufacturing network Extensive Regulatory Portfolio: 46 commercial APIs and 38 US DMFs ensure compliance and market readiness Comprehensive Expertise: a leader in CDMO services for peptides, small molecules, and oligonucleotides Exceptional Leadership: decades of experience drive R&D innovation Environmental Responsibility: committed to sustainability and environmental responsibility in pharmaceutical manufacturing.   📅 Event Details 🗓 March 17-20, 2025 📍 Intercontinental NY Barclay Schedule your meeting today! 👉 Contact Jiuzhou Pharma：https://lnkd.in/eBsJwPVA     Robert Geiger Tim Miley Mark Vermeulen, MBA

Jiuzhou Pharma/九洲药业— From Molecule to Market: Your Trusted Partner 🔗 https://lnkd.in/egR9D-rz 💡 https://lnkd.in/eBsJwPVA   Kai Rossen #FromMoleculeToMarket #TrustedPartner #JiuzhouPharma #SmallMolecules #Peptides #CDMO #Innovation #PharmaceuticalDevelopment #GlobalLeadership

From Molecule to Market: Your Trusted Partner   At Jiuzhou Pharma/九洲药业 , we understand that bringing a #molecule to #market is not just about #chemistry -it’s about trust, collaboration, and expertise. With decades of proven excellence in the #CDMO space, we’ve become the global leader in small molecule and #peptide development.   Why Jiuzhou Pharma? ✔ Comprehensive Solutions: From early-stage R&D to full-scale commercial manufacturing, we support you at every step of your molecule’s journey. ✔ Unmatched Expertise: As pioneers in small molecule and peptide CDMO services, we bring deep scientific knowledge to deliver innovative and efficient solutions. ✔ Global Reach, Local Focus: While headquartered in China, our European and American subsidiaries ensures local CDMO services tailored to meet the specific needs of North American and European customers. ✔ Customer-Centric Approach: We are committed to your success, building partnerships based on transparency, reliability, and shared goals.   Together, we take your vision from concept to commercial reality—quickly, efficiently, and with the utmost precision.   Let’s work together to shape the future of medicine.   #FromMoleculeToMarket #TrustedPartner #JiuzhouPharma #SmallMolecules #Peptides #CDMO #Innovation #PharmaceuticalDevelopment #GlobalLeadership